Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ASCO 2024
Biotech
Fierce Biotech's top 10 editor's picks for 2024
From the conference circuit to the Nasdaq trading floor, we run down some of the highlights from Fierce Biotech's coverage this year.
James Waldron
Dec 23, 2024 3:00am
ASCO: It's back to the basics for cancer drug developers
Jun 5, 2024 10:55am
AbbVie rebuilds ADC portfolio with hope of replacing chemotherapy
Jun 4, 2024 11:26am
Prostate cancer? Ptooey! Saliva test detects aggressive tumors
Jun 3, 2024 1:30pm
Merck's 3-pronged cancer plan stars Moderna-partnered vaccine
Jun 3, 2024 8:00am
ASCO: ConcertAI partners with NVIDIA, launches new AI tools
Jun 2, 2024 10:00am
